Dr Po Inglis
Dr Po Inglis has a Bachelor of Science obtained Monash University 1994, majoring in molecular biology. Her early research work was funded by Anti-Cancer Foundation Grants. During this time she was mentored by Professor Peter Blumbergs at the Hanson Institute of Cancer and Neurological Diseases. After achieving her FRACP in 2009, and whilst working as a full time specialist, she began collaborating with Professor Andrew Boyd and Professor Bryan Day at QIMR Berghofer MRI in the area of brain tumours.
Driven by a motivation to establish translational oncology and a collaboration between the clinic and lab, this has seen the development of KB004 and its role in recurrent GBM early phase clinical trial.
Her major clinical streams at the Royal Brisbane and Women’s Hospital (RBWH) include tarte brain tumours and adolescent and young adult rare tumors, she actively engages in national and international clinical trials, and continues to support scientists in their pursuit to make molecular oncologic discoveries and therapeutic strategies.
Selected Publications
Collins JT, Narayana MJ, Morris K, Casey J, Inglis PL, Cheuk R, Rajah T, Robertson T, Kennedy GA. Adult medulloblastoma: feasibility and effectiveness of utilising high-dose chemotherapy with autologous stem cell rescue in newly diagnosed patients. Intern Med J. 2014 Feb;44(2):209-10. doi: 10.1111/imj.12341
Stephens S, Kuchel A, Cheuk R, Alexander H, Robertson T, Rajah T, Tran Q, Inglis PL. Management trends and outcomes of pineal germinoma in a multi-institutional Australian cohort. J Clin Neurosci. 2021 Aug;90:1-7. doi: 10.1016/j.jocn.2021.05.006